Page last updated: 2024-10-24

busulfan and Focal Nodular Hyperplasia

busulfan has been researched along with Focal Nodular Hyperplasia in 1 studies

Focal Nodular Hyperplasia: Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen.

Research Excerpts

ExcerptRelevanceReference
"The case of a 48-year-old woman in whom focal nodular hyperplasia of the liver developed after busulfan therapy was administered for essential thrombocytosis is described."7.73Focal nodular hyperplasia after busulfan treatment. ( Aldi, M; Bedeschi, E; Bernardi, M; D'Errico, A; Emiliani, F; Foschi, FG; Girelli, F; Marano, G; Musardo, G; Savini, P; Stefanini, GF, 2005)
"The case of a 48-year-old woman in whom focal nodular hyperplasia of the liver developed after busulfan therapy was administered for essential thrombocytosis is described."3.73Focal nodular hyperplasia after busulfan treatment. ( Aldi, M; Bedeschi, E; Bernardi, M; D'Errico, A; Emiliani, F; Foschi, FG; Girelli, F; Marano, G; Musardo, G; Savini, P; Stefanini, GF, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Foschi, FG1
Savini, P1
Marano, G1
Musardo, G1
Bedeschi, E1
Girelli, F1
Emiliani, F1
Aldi, M1
D'Errico, A1
Bernardi, M1
Stefanini, GF1

Other Studies

1 other study available for busulfan and Focal Nodular Hyperplasia

ArticleYear
Focal nodular hyperplasia after busulfan treatment.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:8

    Topics: Busulfan; Female; Focal Nodular Hyperplasia; Humans; Immunosuppressive Agents; Middle Aged; Thromboc

2005